189 results on '"Kitaichi N"'
Search Results
2. Low prevalence of juvenile-onset Behçet’s disease with uveitis in East/South Asian people
- Author
-
Kitaichi, N, Miyazaki, A, Stanford, M R, Iwata, D, Chams, H, and Ohno, S
- Published
- 2009
- Full Text
- View/download PDF
3. Re-evaluation of heterogeneity in HLA-B*510101 associated with Behçetʼs disease
- Author
-
Takemoto, Y., Naruse, T., Namba, K., Kitaichi, N., Ota, M., Shindo, Y., Mizuki, N., Gul, A., Madanat, W., Chams, H., Davatchi, F., Inoko, H., Ohno, S., and Kimura, A.
- Published
- 2008
4. Mutation screening of the CARD15 gene in sarcoidosis
- Author
-
Akahoshi, M., Ishihara, M., Namba, K., Kitaichi, N., Ando, Y., Takenaka, S., Ishida, T., Ohno, S., Mizuki, N., Nakashima, H., and Shirakawa, T.
- Published
- 2008
5. Acute unilateral conjunctivitis after rubella vaccination: the detection of the rubella genome in the inflamed conjunctiva by reverse transcriptase-polymerase–chain reaction
- Author
-
Kitaichi, N, Ariga, T, Ohno, S, and Shimizu, T
- Published
- 2006
6. Increased expression of mucinous glycoprotein KL-6 in human pterygium
- Author
-
Kase, S, Kitaichi, N, Furudate, N, Yoshida, K, and Ohno, S
- Published
- 2006
7. Epstein-Barr virus infected cells in the aqueous humour originated from nasal NK/T cell lymphoma
- Author
-
Kase, S, Namba, K, Kitaichi, N, and Ohno, S
- Published
- 2006
8. Decrease in the glyceraldehyde derived advanced glycation end products in the sera of patients with Vogt-Koyanagi-Harada disease
- Author
-
Kitamura, M, Kitaichi, N, Takeuchi, M, Kitamei, H, Namba, K, Yamagishi, S-i, Iwabuchi, K, Onoé, K, and Ohno, S
- Published
- 2005
9. Identification of a peptide inducing experimental autoimmune uveoretinitis(EAU) in H-2Ak-carrying mice
- Author
-
NAMBA, K., OGASAWARA, K., KITAICHI, N., MATSUKI, N., TAKAHASHI, A., SASAMOTO, Y., KOTAKE, S., MATSUDA, H., IWABUCHI, K., OHNO, S., and ONOÉ, K.
- Published
- 1998
10. Increased expression of mucinous glycoprotein KL-6 in human pterygium
- Author
-
Kase, S., Kitaichi, N., Furudate, N., Yoshida, K., Kase, S., Kitaichi, N., Furudate, N., and Yoshida, K.
- Abstract
Pterygia represent growth onto the cornea of fibrovascular tissue continuous with the conjunctiva.1 KL-6 (Krebs von den Lunge-6) is a high molecular weight mucinous glycoprotein, and the monoclonal antibody reacts with the sugar moiety of MUC-1.2,3 We have reported that measurement of serum KL-6 levels is useful for the diagnosis and management of uveitis patients with sarcoidosis.4,5 The aim of this study was to examine the expression of KL-6, and Ki-67, a proliferation marker, in normal human conjunctiva, pterygium, and pseudopterygium tissues.
- Published
- 2006
11. Acute unilateral conjunctivitis after rubella vaccination: the detection of the rubella genome in the inflamed conjunctiva by reverse transcriptase-polymerase-chain reaction
- Author
-
Kitaichi, N., Ariga, T., Ohno, S., Shimizu, T., Kitaichi, N., Ariga, T., Ohno, S., and Shimizu, T.
- Abstract
The efficacy of long-term rubella vaccine is >90%, and the anti-rubella vaccination causes few side effects.1 Some cases of anterior uveitis were reported after a combined vaccination for measles, mumps and rubella, but not when vaccination for rubella alone was administered.2 Another study reported that, after smallpox vaccination, 16 out of 450 000 subjects vaccinated had ocular complaints including conjunctivitis, keratitis and eyelid oedema, and only 5 of those cases were confirmed positive for vaccinia by culture or PCR.3 However, conjunctivitis after rubella vaccination with laboratory confirmation has never been reported.
- Published
- 2006
12. Epstein-Barr virus infected cells in the aqueous humour originated from nasal NK/T cell lymphoma
- Author
-
Kase, S., Namba, K., Kitaichi, N., Ohno, S., Kase, S., Namba, K., Kitaichi, N., and Ohno, S.
- Abstract
Nasal natural killer (NK)/T cell lymphoma is a definitive diagnostic entity in the World Health Organization lymphoma classification.1 In many cases, NK/T cell lymphoma is invariably associated with Epstein-Barr virus (EBV). Although ocular involvement is found in less than 10% of patients with systemic lymphoma,2 because of its anatomical proximity, nasal NK/T lymphoma can sometimes complicate uveitis and orbital infiltration.3 We experienced a case of nasal NK/T lymphoma, and the cells collected from the aqueous humour originated from the lymphoma which was infected by EBV., www.bmj.com
- Published
- 2005
13. Replication of a microsatellite genome-wide association study of Behcet's disease in a Korean population
- Author
-
Horie, Y., primary, Meguro, A., additional, Kitaichi, N., additional, Lee, E. B., additional, Kanda, A., additional, Noda, K., additional, Song, Y. W., additional, Park, K. S., additional, Namba, K., additional, Ota, M., additional, Inoko, H., additional, Mizuki, N., additional, Ishida, S., additional, and Ohno, S., additional
- Published
- 2012
- Full Text
- View/download PDF
14. Epidemiological and virological features of epidemic keratoconjunctivitis due to new human adenovirus type 54 in Japan
- Author
-
Kaneko, H., primary, Suzutani, T., additional, Aoki, K., additional, Kitaichi, N., additional, Ishida, S., additional, Ishiko, H., additional, Ohashi, T., additional, Okamoto, S., additional, Nakagawa, H., additional, Hinokuma, R., additional, Asato, Y., additional, Oniki, S., additional, Hashimoto, T., additional, Iida, T., additional, and Ohno, S., additional
- Published
- 2010
- Full Text
- View/download PDF
15. Association of TLR4 polymorphisms with Behcet's disease in a Korean population
- Author
-
Horie, Y., primary, Meguro, A., additional, Ota, M., additional, Kitaichi, N., additional, Katsuyama, Y., additional, Takemoto, Y., additional, Namba, K., additional, Yoshida, K., additional, Song, Y. W., additional, Park, K. S., additional, Lee, E. B., additional, Inoko, H., additional, Mizuki, N., additional, and Ohno, S., additional
- Published
- 2009
- Full Text
- View/download PDF
16. Sister cases of Behcet's disease and Vogt-Koyanagi-Harada disease
- Author
-
Horie, Y., primary, Namba, K., additional, Kitaichi, N., additional, and Ohno, S., additional
- Published
- 2008
- Full Text
- View/download PDF
17. Ocular features of Behcet's disease: An international collaborative study
- Author
-
Kitaichi, N., primary, Miyazaki, A., additional, Iwata, D., additional, Ohno, S., additional, Stanford, M. R, additional, and Chams, H., additional
- Published
- 2007
- Full Text
- View/download PDF
18. Increase of macrophage migration inhibitory factor in sera of patients with iridocyclitis
- Author
-
Kitaichi, N., primary
- Published
- 2000
- Full Text
- View/download PDF
19. Identification of a peptide inducing experimental autoimmune uveoretinitis (EAU) in H-2Ak-carrying mice
- Author
-
Namba, K, primary, Ogasawara, K, additional, Kitaichi, N, additional, Matsuki, N, additional, Takahashi, A, additional, Sasamoto, Y, additional, Kotake, S, additional, Matsuda, H, additional, Iwabuchi, K, additional, Ohno, S, additional, and Onoé, K, additional
- Published
- 1998
- Full Text
- View/download PDF
20. Toll-like receptor 2 (TLR2) gene polymorphisms are not associated with sarcoidosis in the Japanese population
- Author
-
Sato M, Kawagoe T, Meguro A, Ota M, Katsuyama Y, Ishihara M, Namba K, Kitaichi N, Morimoto S, Kaburaki T, Yukio Ando, Takenaka S, Ohno S, Inoko H, and Mizuki N
21. Lack of association between toll-like receptor 4 gene polymorphisms and sarcoidosis-related uveitis in Japan
- Author
-
Asukata Y, Ota M, Meguro A, Katsuyama Y, Ishihara M, Namba K, Kitaichi N, Morimoto S, Kaburaki T, Yukio Ando, Takenaka S, Inoko H, Ohno S, and Mizuki N
22. Involvement of Angiopoietin 2 and vascular endothelial growth factor in uveitis.
- Author
-
Suzuki K, Iwata D, Namba K, Hase K, Hiraoka M, Murata M, Kitaichi N, Foxton R, and Ishida S
- Subjects
- Animals, Humans, Mice, Angiopoietin-2 genetics, Disease Models, Animal, Endothelial Cells metabolism, Inflammation pathology, RNA, Messenger metabolism, Vascular Endothelial Growth Factor A genetics, Vascular Endothelial Growth Factors, Autoimmune Diseases, Uveitis
- Abstract
Purpose: Angiopoietin (Ang) 2 is released from vascular endothelial cells by the stimulation of vascular endothelial growth factor (VEGF)A. Ang2 increases the expression of leukocyte adhesion molecules on endothelial cells via nuclear factor κB. The aim of this study was to evaluate the effects of Ang2 and VEGFA on ocular autoimmune inflammation., Methods: We measured the concentrations of Ang2 and VEGFA in vitreous samples among patients with uveitis. Vitreous samples were collected from 16 patients with idiopathic uveitis (uveitis group) and 16 patients with non-inflammatory eye disease (control group). Experimental autoimmune uveoretinitis (EAU) was induced in B10.BR mice with a human interphotoreceptor retinoid-binding protein-derived peptide. The retinochoroidal tissues of the EAU mice were removed, and the mRNA levels of Ang2 and VEGFA were examined. EAU mice treated with anti-Ang2, anti-VEGFA, a combination of anti-Ang2 and anti-VEGFA, anti-Ang2/VEGFA bispecific, or IgG control antibodies were clinically and histopathologically evaluated., Results: The protein levels of Ang2 and VEGFA were significantly higher in the vitreous samples of patients with uveitis than in controls (P<0.05). The retinochoroidal mRNA levels of Ang2 and VEGFA were significantly upregulated in EAU mice compared to controls (n = 6, P<0.05). Although there was no significant difference, treatment with anti-VEGFA antibody reduced the clinical and histopathological scores. However, treatment with anti-Ang2 antibody reduced the clinical and histopathological scores (n = 18-20, P<0.05). Furthermore, these scores were further decreased when treated by inhibiting both Ang2 and VEGFA., Conclusions: Based on these results, VEGFA and Ang2 were shown to be upregulated locally in the eye of both uveitis patients and models of uveitis. Dual inhibition of Ang2 and VEGFA is suggested to be a new therapeutic strategy for uveitis., Competing Interests: RF is an employee of F. Hoffmann-La Roche Ltd. F.Hoffmann-La Roche provided support in the form of salary for the organisation’s author [RF], and he had a role in elements of the study design, and preparation of the manuscript, but no additional roles in the data collection and analysis and decision to publish the manuscript. The specific roles of authors are articulated in the ‘author contributions’ section. DI awarded Grants-in-Aid for Scientific Research by Japanese Society for the Promotion of Science [grant number 16K29294] and a grant of research by AMO Japan (Johnson & Johnson surgical vision) [grant number AS2021A000044497]. This does not alter our adherence to PLOS ONE policies on sharing data and materials., (Copyright: © 2023 Suzuki et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2023
- Full Text
- View/download PDF
23. A case of tubulointerstitial nephritis and uveitis syndrome accompanied by subclinical choroiditis.
- Author
-
Arita T, Namba K, Iwata D, Suzuki K, Ogino Y, Mizuuchi K, Hiraoka M, Kitaichi N, and Ishida S
- Subjects
- Male, Humans, Child, Prednisolone therapeutic use, Retina, Inflammation drug therapy, Uveitis complications, Uveitis diagnosis, Uveitis drug therapy, Nephritis, Interstitial complications, Nephritis, Interstitial diagnosis, Nephritis, Interstitial drug therapy, Papilledema, Choroiditis complications, Choroiditis diagnosis, Choroiditis drug therapy
- Abstract
Background: Tubulointerstitial nephritis and uveitis (TINU) syndrome is an uveits characterized by complications of idiopathic acute tubulointerstitial nephritis, and most cases present only anterior uveitis. We report a case of TINU syndrome in which the presence of choroiditis was revealed by multimodal imaging., Case Presentation: A 12-year-old male visited our hospital with a 6-day history of ocular pain and hyperemia. Conjunctival and ciliary injections, 1 + flare and 3 + cells of anterior chamber inflammation with mutton fat keratic precipitates were observed in both eyes (OU), together with redness and swelling of the optic disc OU. Laboratory tests showed slightly high levels of soluble IL-2R and serum β2 microglobulin and markedly high levels of urinary β2 microglobulin. The diagnosis of probable TINU syndrome was established on the basis of bilateral uveitis and urinalysis results in accordance with a clinical criteria of tubulointerstitial nephritis. With treatment with oral prednisolone (PSL) at 20 mg/day, ocular findings improved, and the dose of PSL was gradually reduced and withdrawn 6 months later. However, 1 month later from the withdrawal, ocular inflammation recurred with the presence of retinal exudates and snowball vitreous opacities in the peripheral retina OU. Fluorescein angiography showed leakages from peripheral retinal vessels and staining corresponding to retinal exudates. Indocyanine green angiography showed hypofluorescent dots scattered over the ocular fundus. Optical coherence tomography revealed the presence of choroidal thickening. Laser speckle flowgraphy color map showed a relatively cooler color. Findings from these multimodal images indicated the presence of subclinical choroiditis; therefore, oral PSL was administered again, and ocular inflammatory findings were improved., Conclusions: TINU syndrome can exhibit subclinical choroiditis detected with multimodal imaging. Further studies are necessary to determine the frequency of subclinical choroiditis in TINU syndrome., (© 2023. BioMed Central Ltd., part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
24. A case of APMPPE-like panuveitis presenting with extensive outer retinal layer impairment following COVID-19 vaccination.
- Author
-
Ogino Y, Namba K, Iwata D, Suzuki K, Mizuuchi K, Hiraoka M, Kitaichi N, and Ishida S
- Subjects
- Adult, Female, Humans, Inflammation, Retina, COVID-19 prevention & control, COVID-19 Vaccines adverse effects, Panuveitis diagnosis, Panuveitis etiology, Retinal Detachment, White Dot Syndromes
- Abstract
Background: Vaccination against the worldwide pandemic coronavirus disease 2019 (COVID-19) is underway; however, some cases of new onset uveitis after vaccination have been reported. We report a case of bilateral acute posterior multifocal placoid pigment epitheliopathy-like (AMPPE-like) panuveitis after COVID-19 vaccination in which the patient's pathological condition was evaluated using multimodal imaging., Case Presentation: A 31-year-old woman experienced bilateral hyperemia and blurred vision starting 6 days after her second inoculation of the COVID-19 vaccination. At her first visit, her visual acuity was decreased bilaterally, and severe bilateral anterior chamber inflammation and bilateral scattering of cream-white placoid lesions on the fundus were detected. Optical coherence tomography (OCT) showed serous retinal detachment (SRD) and choroidal thickening in both eyes (OU). Fluorescein angiography (FA) revealed hypofluorescence in the early phase and hyperfluorescence in the late phase corresponding to the placoid legions. Indocyanine green angiography (ICGA) showed sharply marginated hypofluorescent dots of various sizes throughout the mid-venous and late phases OU. The patient was diagnosed with APMPPE and was observed without any medications. Three days later, her SRD disappeared spontaneously. However, her anterior chamber inflammation continued, and oral prednisolone (PSL) was given to her. Seven days after the patient's first visit, the hyperfluorescent lesions on FA and hypofluorescent dots on ICGA partially improved; however, the patient's best corrected visual acuity (BCVA) recovered only to 0.7 OD and 0.6 OS, and the impairment of the outer retinal layer was broadly detected as hyperautofluorescent lesions on fundus autofluorescence (FAF) examination and as irregularity in or disappearance of the ellipsoid and interdigitation zones on OCT, which were quite atypical for the findings of APMPPE. Steroid pulse therapy was performed. Five days later, the hyperfluorescence on FAF had disappeared, and the outer retinal layer improved on OCT. Moreover, the patient's BCVA recovered to 1.0 OU. Twelve months after the end of treatment, the patient did not show any recurrences., Conclusions: We observed a case of APMPPE-like panuveitis after COVID-19 vaccination featuring some atypical findings for APMPPE. COVID-19 vaccination may induce not only known uveitis but also atypical uveitis, and appropriate treatment is required for each case., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
25. The Steroid-Sparing Effect of Adalimumab in the Treatment for the Recurrent Phase of Vogt-Koyanagi-Harada Disease.
- Author
-
Shinagawa M, Namba K, Mizuuchi K, Iwata D, Hase K, Suzuki K, Hirooka K, Kitaichi N, Hiraoka M, and Ishida S
- Subjects
- Humans, Adalimumab therapeutic use, Retrospective Studies, Prednisolone therapeutic use, Cyclosporine therapeutic use, Steroids therapeutic use, Uveomeningoencephalitic Syndrome diagnosis, Uveomeningoencephalitic Syndrome drug therapy
- Abstract
Purpose: To reveal the steroid-sparing effect of adalimumab (ADA) in the treatment for the chronic recurrent phase of Vogt-Koyanagi-Harada (VKH) disease., Cases and Methods: Thirty-six eyes from 18 cases of the recurrent phase of VKH disease treated with ADA over 12 months were examined retrospectively. Before the introduction of ADA, 4 cases received prednisolone (PSL) monotherapy and other 14 cases received PSL and cyclosporine A (CYA) combination therapy., Results: In cases treated with PSL and CYA, CYA was discontinued when ADA was introduced. The minimum dose of PSL to control intraocular inflammation (min dose of PSL) could be reduced in all cases after the introduction of ADA (from 16.9 ± 7.9 mg to 6.3 ± 3.1 mg). No serious adverse events were observed in the observational periods., Conclusion: By comparing the min dose of PSL before and after the introduction of ADA, the steroid-sparing effect of ADA was confirmed.
- Published
- 2023
- Full Text
- View/download PDF
26. Adenovirus-Associated Uveitis with Necrotizing Retinitis.
- Author
-
Sugita S, Usui Y, Watanabe H, Panto L, Iida M, Suginoshita K, Koyanagi KO, Nishida A, Kurimoto Y, Takahashi M, Shindo T, Nishioka H, Takano M, Kezuka T, Goto H, and Kitaichi N
- Subjects
- Humans, Adenoviridae, Uveitis diagnosis, Uveitis complications, Retinitis diagnosis, Cytomegalovirus Retinitis complications
- Published
- 2023
- Full Text
- View/download PDF
27. Clinical significance of serum and vitreous soluble interleukin-2 receptor in patients with intraocular lymphoma.
- Author
-
Suzuki K, Namba K, Kase S, Ogino Y, Hase K, Iwata D, Mizuuchi K, Hiraoka M, Kitaichi N, and Ishida S
- Subjects
- Humans, Matrix Metalloproteinase 9, Matrix Metalloproteinase 2, Reproducibility of Results, Receptors, Interleukin-2, Biomarkers, Tumor, Intraocular Lymphoma, Central Nervous System Neoplasms, Uveitis diagnosis, Eye Neoplasms diagnosis
- Abstract
Background: Intraocular lymphoma (IOL) is a masquerade syndrome that mimics uveitis, making diagnosis difficult. The serum soluble interleukin-2 receptor (sIL-2R), which is cleaved by matrix metalloproteinase (MMP) -2 and MMP-9, has been recognized as a tumor-related biomarker of malignant lymphomas. The aim of this study was to review the reliability of serum and vitreous sIL-2R for distinguishing IOL from uveitis., Methods: Patients who underwent diagnostic vitrectomy for marked vitreous haze at Hokkaido University Hospital between April 2014 and June 2019 were enrolled. The patients were divided into an IOL group and a uveitis group, according to the pathology of their vitreous samples. The IOL group was further divided at the time of vitrectomy into patients who already had extraocular involvement (IOL with extraocular involvement group) and patients with no evidence of having extraocular involvement (IOL without extraocular involvement group). Serum sIL-2R, and intravitreal sIL-2R, MMP-2, and MMP-9 levels were assessed., Results: Twenty-five eyes of 25 patients, and 15 eyes of 15 patients were included in the IOL group and uveitis group, respectively. The serum sIL-2R levels were significantly lower in the IOL group than in the uveitis group (P < 0.05), and 20.0% and 66.7% in the IOL and the uveitis group showed high sIL-2R value above the normal range. Vitreous sIL-2R tended to be higher in the IOL group than in the uveitis group (P = 0.80). Serum sIL-2R was significantly lower in the IOL without extraocular involvement group than in the IOL with extraocular involvement group (P < 0.05); 5.9% in the IOL without extraocular involvement group and 50.0% in the IOL with extraocular involvement group showed high sIL-2R value above the normal range. Vitreous sIL-2R, MMP-2, and MMP-9 tended to be higher in the IOL with extraocular involvement group than in the IOL without extraocular involvement group (P = 0.30, < 0.05, 0.16)., Conclusions: Serum sIL-2R is often within the normal range in IOL patients. Even if it is within the normal range, the possibility of IOL should be considered. Serum sIL-2R is not a reliable biomarker for IOL, whereas vitreous sIL-2R may be useful for the diagnosis of IOL., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
28. Fundus autofluorescence imaging in acute posterior multifocal placoid pigment epitheliopathy.
- Author
-
Yokoi K, Namba K, Iwata D, Mizuuchi K, Hase K, Suzuki K, Ando R, Hirooka K, Sekine N, Kitaichi N, Hiraoka M, and Ishida S
- Abstract
Purpose: Acute posterior multifocal placoid pigment epitheliopathy (APMPPE) is a disease characterized by multiple yellowish-white placoid lesions. Although most lesions resolve spontaneously, some turn into scars and lead to permanent visual dysfunction. In this report, we found suggestive findings in fundus autofluorescence (FAF) that may be useful for distinguishing severe lesions requiring treatment in APMPPE., Observation: Case 1: A 29-year-old woman was referred to our hospital with multiple yellowish-white placoid lesions on the fundi of both eyes (OU). FAF showed hyperautofluorescence in some of these placoid lesions. Based on the findings of fluorescein angiography, a diagnosis of APMPPE was established, and oral prednisolone (PSL) was initiated, given that some lesions were located in the macula. One week later, exacerbation occurred with the newly developed hyperautofluorescent lesions. Some lesions in the right eye (OD) that were hyperautofluorescent at the first visit became hypoautofluorescent. Afterward, although all hypoautofluorescent lesions persisted, most of the hyperautofluorescent lesions disappeared, so oral PSL could be stopped. Two months later, however, the recurrence occurred along with multiple new placoid lesions. Some lesions located at the macula were hyperautofluorescent on FAF OU, indicating the possibility of becoming scar lesions with hypoautofluorescence. Accordingly, oral PSL was given again., Case 2: A 47-year-old woman noticed decreased vision OD, and she was referred to us. Multiple yellowish-white placoid lesions were seen in the fundi OU. FAF showed hyperautofluorescence both with and without corresponding hypoautofluorescence in the placoid lesions OU. A diagnosis of APMPPE was established, and oral PSL was initiated. Four months later, some lesions that were hyperautofluorescent at the first visit had turned isoautofluorescent, and some lesions OU became hypoautofluorescent. However, all hypoautofluorescent lesions remained hypoautofluorescent OU. Only some hyperautofluorescent lesions recovered to isoautofluorescence without scars., Conclusions and Importance: In APMPPE, lesions showing hyperautofluorescence on FAF may change into hypoautofluorescence indicating scar formation. Therefore, the presence of hyperautofluorescent lesions in the macula may be a good indicator of the need for intensive corticosteroid treatments to avoid leaving hypoautofluorescent scars that are related to irreversible visual dysfunction., Competing Interests: The authors declare that they have no competing interests., (© 2022 The Authors.)
- Published
- 2022
- Full Text
- View/download PDF
29. Clinical features of ocular sarcoidosis: severe, refractory, and prolonged inflammation.
- Author
-
Suzuki K, Ishihara M, Namba K, Ohno S, Goto H, Takase H, Kawano S, Shibuya E, Hase K, Iwata D, Mizuuchi K, Kitaichi N, Mizuki N, and Ishida S
- Subjects
- Female, Humans, Inflammation complications, Longitudinal Studies, Male, Retrospective Studies, Vision Disorders, Endophthalmitis complications, Glaucoma complications, Macular Edema etiology, Sarcoidosis complications, Sarcoidosis diagnosis, Sarcoidosis epidemiology
- Abstract
Purpose: To clarify the proportion of ocular sarcoidosis with severe, refractory, and prolonged inflammation and their association with ocular complications and visual prognosis., Study Design: Multicenter, retrospective, longitudinal cohort study., Methods: Three hundred and twenty-three eyes of 164 patients (45 men; 119 women) with ocular sarcoidosis who visited Hokkaido University Hospital and Yokohama City University Hospital from 2010 to 2015. We newly defined severe, refractory, and prolonged inflammation in ocular sarcoidosis, and investigated their proportions, ocular complications and final visual acuity from medical records of our sarcoidosis patients., Results: The eyes with severe inflammation numbered 72/323 (22.3%), with refractory inflammation, 80/323 (24.8%), and with prolonged inflammation, 91/323 (28.2%). The number of eyes having neither severe, refractory, nor prolonged inflammation (defined as none) was 114/323 (35.3%). The numbers of eyes that reached irreversible visual dysfunction were 6/72 (8.3%) of those with severe inflammation, 10/80 (12.5%) with refractory inflammation, 12/91 (13.2%) with prolonged inflammation, and 4/114 (6.2%) with none. As complications, cataract (62.2%), glaucoma (28.5%), epiretinal membrane (24.1%), cystoid macular edema (22.6%), vitreous hemorrhage (2.8%), choroidal atrophy (2.5%), macular degeneration (1.2%), macular hole (0.9%) and retinal detachment (0.3%) were identified. Among them, secondary glaucoma (16 eyes) and macular degeneration (4 eyes) were major complications related to irreversible visual dysfunction., Conclusions: Although most of the patients with ocular sarcoidosis had a relatively good visual prognosis, some developed severe, refractory, and/or prolonged inflammation related to the development of ocular complications, that resulted in poor visual prognosis., (© 2022. Japanese Ophthalmological Society.)
- Published
- 2022
- Full Text
- View/download PDF
30. Recent Clinical Features of Intraocular Inflammation in Hokkaido, Japan - Comparison with the Previous Decade.
- Author
-
Iwata D, Namba K, Yamamoto T, Mizuuchi K, Saito W, Ohno S, Kitaichi N, and Ishida S
- Subjects
- Female, Humans, Inflammation complications, Japan epidemiology, Male, Retrospective Studies, Vitreous Body, Behcet Syndrome complications, Behcet Syndrome diagnosis, Behcet Syndrome epidemiology, Retinal Neoplasms, Sarcoidosis complications, Sarcoidosis diagnosis, Sarcoidosis epidemiology, Uveitis diagnosis, Uveitis epidemiology, Uveitis etiology
- Abstract
Purpose: This study aimed to investigate the clinical features of intraocular inflammation (uveitis) in Hokkaido and to assess the etiology trends in comparison with those of our previous survey., Methods: We retrospectively reviewed the medical records of 1,616 new referral uveitis patients (1,020 females and 596 males) in Hokkaido University Hospital between 2004 and 2014., Results: Sarcoidosis was the most frequent etiology (17.4%), followed by Vogt-Koyanagi-Harada disease (8.1%), Behçet's disease (4.5%), and human leukocyte antigen B27 -associated uveitis (2.5%). The etiologies in 48.7% of the patients were unclassified. Compared to the previous survey between 1994 and 2003, the rate of Behçet's disease decreased and that of sarcoidosis increased. The rates of infectious uveitis and vitreoretinal lymphoma increased., Conclusion: Although the order of the top four etiologies was the same in the two surveys, the rate of sarcoidosis increased and that of Behçet's disease decreased.
- Published
- 2022
- Full Text
- View/download PDF
31. Diagnostic Accuracy of Cell Block Preparations and Clinical Features Affecting It in Vitreoretinal Lymphoma.
- Author
-
Kase S, Namba K, Iwata D, Mizuuchi K, Suzuki K, Ito T, Hase K, Kitaichi N, and Ishida S
- Abstract
Purpose: The purpose of this study was to examine the diagnostic accuracy of the cell block (CB) method and clinical features affecting it in patients with vitreoretinal lymphoma (VRL). Methods: This study enrolled 38 eyes in 33 VRL patients, and 7 eyes in 7 patients with idiopathic uveitis who underwent diagnostic vitrectomy. Medical records including the results of CB cytology, interleukin (IL)-10/-6 concentrations, and immunoglobulin heavy chain gene (IgH) rearrangement were retrospectively searched. Results: Patients with VRL comprised 16 women and 17 men, and the age of onset ranged from 44 to 85 years (mean: 70 years). CB preparations detected large malignant cells in 35 eyes (92%), whereas the other 3 VRL eyes were negative. Two of the latter three eyes showed subretinal infiltrates, which existed in 7 of 35 CB-positive eyes. Intravitreal IL-10 and -6 concentrations were 1866 ± 4088 pg/mL and 98 ± 139 pg/mL, respectively, and the rate of IL-10/-6 >1 was 86.9%. The presence of IgH monoclonality was 63.2%. In patients with uveitis, CB specimens revealed no atypical but small inflammatory cells. IL-6 concentration was 311.1 ± 240 pg/mL, whereas IL-10 was undetectable in six eyes, and the IL-negative rate was 85.7%. Six eyes (85.7%) with uveitis showed no IgH monoclonality. Conclusions: Diagnostic accuracy of CB preparations in VRL could achieve an equivalent outcome to IL ratio calculation and IgH monoclonality detection. The appearance of subretinal infiltrates may diminish the CB positivity.
- Published
- 2022
- Full Text
- View/download PDF
32. A case of Epstein-Barr virus acute retinal necrosis successfully treated with foscarnet.
- Author
-
Suzuki K, Namba K, Hase K, Mizuuchi K, Iwata D, Ito T, Kitaichi N, Takase H, and Ishida S
- Abstract
Purpose: Epstein-Barr virus (EBV) is a herpes virus known to cause infectious mononucleosis and several other human disorders. Ocular EBV infections that have been reported include uveitis, retinal vasculitis, and acute retinal necrosis (ARN). ARN is usually caused by herpes simplex virus (HSV) or varicella-zoster virus (VZV). ARN that is caused by EBV (EBV-ARN) is rarely seen, and only a few cases have been reported. The visual prognosis for EBV-ARN is poor, and no treatment strategy has been established. We report on a patient who was treated successfully for EBV-ARN., Observation: An 80-year-old female who had been treated with prednisolone at 5 mg/day and methotrexate at 2 mg/week for rheumatoid arthritis visited our hospital because of blurred vision in her left eye. Her left visual acuity was 20/50, and extensive white-yellowish retinal lesions at the temporal periphery with retinal hemorrhages were seen through vitreous haze. The DNA sequence of EBV, but not of HSV, VZV, or cytomegalovirus, was detected by a polymerase chain reaction (PCR) assay in the aqueous humor (4.2 × 10
6 copies/ml), with EBV also being positive in serum (3.5 × 102 copies/ml). The patient received 2 mg of intravitreal ganciclovir injections twice with a 3-day interval and intravenous infusion of acyclovir at 750 mg/day for 7 days; however, the retinal white lesions expanded rapidly, then dose of prednisolone was increased (40 mg/day) and vitrectomy was performed 10 days after the initial visit. After the surgery, the retinal lesion continued to enlarge. Vitreous samples showed high copies of EBV (1.2 × 108 copies/ml). Following treatment with intravenous foscarnet (4800 mg/day), which replaced the acyclovir application, the retinal white lesions gradually diminished, leaving retinal scars. To date, the patient has developed no retinal detachment and shows visual acuity over 6/60 in the left eye along with silicone oil., Conclusions: We experienced a case of EBV-ARN that was refractory to systemic acyclovir and topical ganciclovir but responded effectively to systemic foscarnet after vitrectomy. Although the clinical management remains challenging in this disease, foscarnet is considered to be one of the candidate drugs for EBV infections., Competing Interests: The authors declare that they have no competing interests., (© 2022 The Authors.)- Published
- 2022
- Full Text
- View/download PDF
33. Macrophage-like iPS-derived Suppressor Cells Reduce Th1-mediated Immune Response to a Retinal Antigen.
- Author
-
Hase K, Namba K, Wada H, Tsuji H, Maeda A, Murata T, Otsuka R, Iwata D, Kanda A, Noda K, Kitaichi N, Seino KI, and Ishida S
- Subjects
- Animals, Autoimmune Diseases pathology, Cells, Cultured, Disease Models, Animal, Induced Pluripotent Stem Cells cytology, Lymphocyte Activation, Macrophages immunology, Macrophages pathology, Male, Mice, Mice, Inbred C57BL, Retinitis pathology, Th1 Cells pathology, Uveitis pathology, Antigens immunology, Autoimmune Diseases immunology, Eye Proteins metabolism, Induced Pluripotent Stem Cells immunology, Retinitis immunology, Retinol-Binding Proteins metabolism, Th1 Cells immunology, Uveitis immunology
- Abstract
Purpose: To investigate the immunotherapeutic effects of macrophage-like induced pluripotent stem (iPS) cell-derived suppressor cells (SCs) in ocular immune response and experimental autoimmune uveoretinitis (EAU)., Methods: The genes of Oct3/4, Sox2, Klf4 , and c-Myc were transferred to B cells enriched from the spleen cells of C57BL/6 mice by using retrovirus vectors. Transferred B cells were cultured for 17 days to obtain colonies of iPS cells. Through additional steps, iPS-SCs were induced. An antigen-specific T cell proliferation assay was performed with CD4
+ T cells collected from draining lymph nodes of the mice immunized with human interphotoreceptor retinoid-binding protein (hIRBP) peptide and co-cultured with iPS-SCs. Cytokine concentrations in the culture supernatant were examined. Mice were immunized with hIRBP peptide to induce EAU. The iPS-SCs were administered into the mice one day before the induction of EAU., Results: The iPS-SCs decreased hIRBP-specific T cell proliferation depending on the number of cells. Productions of tumor necrosis factor-α and interferon-γ were significantly decreased; however, transforming growth factor-β1, nitric oxide, interleukin (IL)-13, IL-17A, and IL-17 F levels were elevated in the supernatant when the collected T cells were co-cultured with iPS-SCs. The iPS-SCs had immunosuppressant effects even without cell-to-cell contact, and their effects were non-specific to the antigen preloaded on iPS-SCs. EAU was significantly milder in the mice administered iPS-SCs prior to immunization., Conclusions: Macrophage-like iPS-SCs reduced Th1 immune response to a retinal antigen and Th1-mediated EAU in mice. These results showed the possibility of the application of iPS technology to the treatment of noninfectious ocular inflammation, endogenous uveitis, in the future.- Published
- 2021
- Full Text
- View/download PDF
34. Clinical Features of Primary Vitreoretinal Lymphoma: A Single-center Study.
- Author
-
Kase S, Namba K, Iwata D, Mizuuchi K, Ito T, Hase K, Suzuki K, Onozawa M, Kitaichi N, and Ishida S
- Abstract
Background/aim: This study aimed to demonstrate the clinical outcomes of primary vitreoretinal lymphoma (PVRL)., Patients and Methods: Seventeen patients with PVRL who had been treated at Hokkaido University Hospital were enrolled in this study. They were diagnosed based on their cytology, interleukin-10/-6 ratio, and immunoglobulin heavy chain (IgH) gene rearrangement., Results: Diagnostic tests detected cytological malignancy among 14 cases (82.3%), high interleukin-10/-6 ratios among 16 cases (94.1%), and IgH monoclonality in 13 cases (76.5%). Systemic corticosteroids were given to seven (41.2%) patients before their diagnosis of PVRL. Treatments after diagnosis comprised intravitreal methotrexate injection, local radiation, and intravenous chemotherapy for 11, seven, and five cases, respectively. Central nervous system and systemic involvements were observed in nine and one case, respectively, and these complications occurred at 3 to 43 months (mean=16 months) after initial ocular presentation., Conclusion: Many of our patients did not receive any systemic intervention, and almost half of patients with PVRL developed central nervous system involvement during their follow-up period., Competing Interests: The Authors declare that we have no conflicts of interest., (Copyright 2021, International Institute of Anticancer Research.)
- Published
- 2021
- Full Text
- View/download PDF
35. Development of cytomegalovirus retinitis after negative conversion of cytomegalovirus antigenemia due to systemic antiviral therapy.
- Author
-
Suzuki K, Namba K, Mizuuchi K, Iwata D, Ito T, Hase K, Kitaichi N, and Ishida S
- Subjects
- Antigens, Viral, Antiviral Agents therapeutic use, Ganciclovir therapeutic use, Humans, Retrospective Studies, Cytomegalovirus, Cytomegalovirus Retinitis diagnosis, Cytomegalovirus Retinitis drug therapy
- Abstract
Purpose: Cytomegalovirus (CMV) antigenemia assays have been widely used as adjunct tests to diagnose tissue invasive CMV diseases, including cytomegalovirus retinitis (CMVR). In this study, we examined CMVR cases to assess the presence of CMV in sera and aqueous humor and antiviral therapy received prior to the onset of CMVR., Methods: A total of 37 eyes from 26 different cases of CMVR in patients who visited Hokkaido University Hospital between 2007 and 2015 were enrolled. The diagnosis of CMVR was established based on characteristic ophthalmoscopic findings and the presence of local and/or systemic CMV infection. Among the 26 cases, 3 cases (12%) were HIV-positive, while the other 23 cases (88%) were HIV-negative. The records of clinical and laboratory results were reviewed from clinical charts retrospectively., Results: CMV antigenemia was positive at the onset of CMVR in 14 cases (53.8%) and negative in the other 12 cases. In 9 cases among the antigenemia-negative cases (75.0%), the antigenemia had been previously positive and had turned negative before the onset of CMVR. In 12 of the 14 antigenemia-positive cases (85.7%) and in 8 of the 9 antigenemia-negative cases (88.9%) that were previously positive, systemic antiviral therapies had never been used or had been used before but had been discontinued prior to the onset of CMVR., Conclusion: Even if viremia turns negative, the risk of developing CMVR exists for more than several weeks after the completion of systemic therapy.
- Published
- 2021
- Full Text
- View/download PDF
36. Correction to: Development of cytomegalovirus retinitis after negative conversion of cytomegalovirus antigenemia due to systemic antiviral therapy.
- Author
-
Suzuki K, Namba K, Mizuuchi K, Iwata D, Ito T, Hase K, Kitaichi N, and Ishida S
- Published
- 2021
- Full Text
- View/download PDF
37. Disinfectant potential in inactivation of epidemic keratoconjunctivitis-related adenoviruses by potassium peroxymonosulfate.
- Author
-
Hashizume M, Aoki K, Ohno S, Kitaichi N, Yawata N, Gonzalez G, Nonaka H, Sato S, and Takaoka A
- Subjects
- A549 Cells, Cross Infection prevention & control, Epidemics, Humans, Virus Replication drug effects, Adenovirus Infections, Human virology, Adenoviruses, Human drug effects, Disinfectants pharmacology, Keratoconjunctivitis virology, Oxidants pharmacology, Peroxides pharmacology
- Abstract
Purpose: The aim of this study was to test the antiviral effectivity of potassium peroxymonosulfate (RUBYSTA
® , KYORIN) against five epidemic keratoconjunctivitis-related types of Human adenovirus D in vitro., Methods: Five types of Human adenovirus D (8, 37, 53, 54 and 56) were incubated with 1% potassium peroxymonosulfate, 0.1% sodium hypochlorite (NaClO) or alcohol-based disinfectant for 30 s or 1 min. These solutions were subjected to measurements of viral titres by infection assays in A549 cells. At day 6 post-infection, both, supernatants and cells, were collected and the viral genome was assessed by real-time polymerase chain reaction analysis., Results: Treatments with 1% potassium peroxymonosulfate led to significant reduction in all tested Human adenovirus D types comparable to disinfecting effects by 0.1% NaClO. Overall, potassium peroxymonosulfate demonstrated sufficient inactivation of the major epidemic keratoconjunctivitis-causing Human adenovirus D to be considered for disinfection and prevention purposes in ophthalmological clinics and hospitals., Conclusion: This study demonstrated that potassium peroxymonosulfate is a promising disinfectant for the prevention of epidemic keratoconjunctivitis nosocomial infections in ophthalmological clinics.- Published
- 2021
- Full Text
- View/download PDF
38. Validation of systemic parameters for the diagnosis of ocular sarcoidosis.
- Author
-
Suzuki K, Namba K, Mizuuchi K, Iwata D, Ito T, Hase K, Kitaichi N, and Ishida S
- Subjects
- Biomarkers, Female, Humans, Male, Receptors, Interleukin-2, Retrospective Studies, Sarcoidosis diagnosis, Uveitis
- Abstract
Purpose: Ocular sarcoidosis is diagnosed based on suggestive intraocular findings and systemic investigations. In this study, we assessed the clinical usefulness of systemic parameters in the diagnosis of ocular sarcoidosis., Study Design: A retrospective study., Methods: This study included 79 cases (19 men, 60 women) with ocular sarcoidosis who visited Hokkaido University Hospital from 2011 to 2015 and were followed up for more than one year. The control group was 91 cases of other uveitis (38 men, 53 women). All cases underwent blood examination for the measurement of angiotensin-converting enzyme (ACE), Krebs von den Lungen-6 (KL-6), soluble interleukin-2 receptor (sIL-2R), and calcium (Ca) levels. Bilateral hilar lymphadenopathy (BHL) was also examined by plain chest X-ray and contrasting chest computed tomography (CT)., Results: The sensitivity for sIL-2R (76.4%) was higher than for ACE (37.7%), KL-6 (26.3%), and Ca (11.8%), although all showed high specificity: ACE (97.5%), KL-6 (96.2%), sIL-2R (93.8%), and Ca (95.1%). From these results, the Youden index of sIL-2R (0.70) was higher than that of ACE (0.35), KL-6 (0.26), and Ca (0.07). Imaging tests revealed better detection of BHL by contrasting chest CT (82.7%) than by plain chest X-ray (29.5%)., Conclusion: The present findings indicate that the systemic parameters, particularly serum sIL-2R levels and BHL on contrasting chest CT, are useful biomarkers for the diagnosis of ocular sarcoidosis.
- Published
- 2021
- Full Text
- View/download PDF
39. The protective function of invariant natural killer T cells in the relapse of experimental autoimmune uveoretinitis.
- Author
-
Tajiri N, Kato T, Satoh M, Iizuka M, Taniguchi M, Kitaichi N, and Iwabuchi K
- Subjects
- Animals, Autoimmune Diseases immunology, Cell Proliferation, Eye Proteins toxicity, Female, Flow Cytometry, Lymphocyte Activation, Mice, Mice, Inbred C57BL, Recurrence, Retinitis immunology, Retinol-Binding Proteins toxicity, Th1 Cells immunology, Th17 Cells immunology, Th2 Cells immunology, Uveitis immunology, Autoimmune Diseases prevention & control, Disease Models, Animal, Natural Killer T-Cells physiology, Retinitis prevention & control, Uveitis prevention & control
- Abstract
Experimental autoimmune uveoretinitis (EAU) in mice provides a useful platform to study the pathogenesis and experimental therapeutics of human uveitis. One often used EAU model employs C57BL/6 (B6) mice sensitized with a peptide residue having 1 to 20 amino acids of human interphotoreceptor retinoid binding protein (hIRBP
1-20 ). The model using the B6 background has permitted a liberal use of genetically engineered strains and has provided insights for understanding uveoretinitis. However, this is usually acute/monophasic and does not represent human uveoretinitis that is characterized as a chronic/recurrent disease. Several chronic/recurrent EAU models have been developed; of these, we employed administration of staphylococcal enterotoxin B (SEB) for relapse in the present study, and found that recurrence was induced at day 24 after primary immunization, which is thought to be the convalescent phase. We reported the activation of invariant natural killer T (iNKT)-cells upon primary immunization of the EAU model mice with the ligand RCAI-56, which was found to mitigate the disease in our previous study. Here, we first attempted to ameliorate EAU in the relapse model using a preventive regimen by activating iNKT cells at the same time relapse induction (day 24) or in a regimen after 3 days of relapse induction (day 27). The preventive as well as post-inductive regimens were successful in reducing histopathological scores by inhibiting the Ag-specific Th17-biased response. Collectively, activation of iNKT cells may be useful to mitigate the relapse response of EAU induced with SEB., (Copyright © 2020 Elsevier Ltd. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
40. Multimodal Imaging in Ocular Sarcoidosis.
- Author
-
Mahendradas P, Maruyama K, Mizuuchi K, Kawali A, and Kitaichi N
- Subjects
- Coloring Agents administration & dosage, Fluorescein Angiography, Humans, Indocyanine Green administration & dosage, Optical Imaging, Tomography, Optical Coherence, Eye Diseases diagnostic imaging, Multimodal Imaging, Sarcoidosis diagnostic imaging
- Abstract
Aim: Ocular sarcoidosis presents a diagnostic challenge because of its varied clinical presentations. It is important to distinguish sarcoidosis from other uveitis diseases. Multimodal imaging provides useful data to be introduced into clinical practice. Methods: This is a review article. Conclusions: This review article highlights the role of fundus fluorescein angiography (FA), indocyanine green angiography (ICG), optical coherence tomography (OCT), and optical coherence tomography angiography (OCTA) in the diagnosis and management of ocular sarcoidosis. This review article highlights the role of fundus fluorescein angiography (FA), indocyanine green angiography (ICG), optical coherence tomography (OCT), and optical coherence tomography angiography (OCTA) in the diagnosis and management of ocular sarcoidosis.
- Published
- 2020
- Full Text
- View/download PDF
41. Clinical Effects of Dietary Supplementation of Lutein with High Bio-Accessibility on Macular Pigment Optical Density and Contrast Sensitivity: A Randomized Double-Blind Placebo-Controlled Parallel-Group Comparison Trial.
- Author
-
Machida N, Kosehira M, and Kitaichi N
- Subjects
- Adult, Aged, Biological Availability, Double-Blind Method, Female, Glare, Healthy Volunteers, Humans, Macular Degeneration prevention & control, Male, Middle Aged, Visual Acuity, Young Adult, Contrast Sensitivity drug effects, Dietary Supplements, Lutein blood, Lutein pharmacokinetics, Macular Pigment metabolism
- Abstract
Improvements in macular pigment optical density (MPOD) and contrast sensitivity after administration of 12 mg lutein alone and the timing at which efficacy is observed remain unknown. Therefore, lutein (12 mg), a crystalline formulation, was used in this study, considering its bioaccessibility. This study aimed to determine the effects of lutein administration for 16 weeks on MPOD, contrast sensitivity, and glare sensitivity, and changes in serum lutein levels were determined. The study subjects comprised 59 healthy male and female adults aged 20-69 years. The study diet included a placebo (placebo group) or a diet supplemented with 12 mg of lutein (lutein group). Each study diet was continuously administered for 16 weeks. At weeks 8 and 16, MPOD, contrast sensitivity, glare sensitivity, and serum lutein levels were evaluated. Compared with the placebo group, the lutein group showed significantly improved MPOD, contrast sensitivity, and glare sensitivity at week 16 and significantly increased serum lutein levels at weeks 8 and 16. Continuous administration of lutein for 16 weeks, considering its bioaccessibility, increased MPOD; it made the outlines of visible objects clearer and was effective in inhibiting decreases in visual function caused by glare from light.
- Published
- 2020
- Full Text
- View/download PDF
42. Alteration of oral flora in Mongolian patients with Behçet's disease: a multicentre study.
- Author
-
Balt J, Uehara O, Abiko Y, Jamyanjav B, Jav S, Nagasawa T, Mori M, Horie Y, Fujita M, Lennikov A, Ohta T, Hiraoka M, Iwata D, Namba K, Ohno S, and Kitaichi N
- Subjects
- Bacteria genetics, Humans, RNA, Ribosomal, 16S genetics, Saliva, Behcet Syndrome diagnosis, Stomatitis, Aphthous
- Abstract
Objectives: Behçet's disease (BD) is characterised by repeated acute inflammatory attacks with aphthous ulcers of the oral mucosa, uveitis of the eyes, skin symptoms, and genital ulcers. Although its aetiology is still unknown, there is evidence of the involvement of oral bacteria in systemic diseases. Various types of oral bacteria may be involved in the development and progression of BD. The present study investigated alterations in the oral flora of patients with BD in Mongolia. We collected saliva samples from the Mongolian BD group and healthy control (HC) group, and the oral flora were analysed using next-generation sequencer (NGS)., Methods: DNA was extracted from the unstimulated saliva samples from the 47 BD and 48 HC subjects. The DNA was amplified from the V3-V4 region of 16S rRNA using PCR, and the data were acquired using NGS. Based on the obtained data, we analysed the alpha diversity, beta diversity, and bacterial taxonomy of the salivary flora., Results: Beta diversity differed significantly between the BD and HC flora, but no significant differences were observed in alpha diversity. We found that the proportions of three genera - an S24-7 family unknown species, a mitochondria family unknown species, and Akkermansia species associated with IL-10 production - were significantly lower in the BD than in the HC group., Conclusions: The reduced proportions of the S24-7 family and symbiotic Akkermansia species may be key phenomena in the oral flora of patients with BD.
- Published
- 2020
43. Clinical features of Behcet's disease in Mongolia: a multicenter study.
- Author
-
Balt J, Jamyanjav B, Jav S, Dandii Z, Ganbold C, Horie Y, Lennikov A, Uehara O, Ohno S, and Kitaichi N
- Subjects
- Adolescent, Adult, Aged, Child, Eye, Female, Headache, Humans, Male, Middle Aged, Mongolia epidemiology, Young Adult, Behcet Syndrome complications, Behcet Syndrome diagnosis, Behcet Syndrome epidemiology, Stomatitis, Aphthous
- Abstract
Objective: The aim of the present study is to investigate the clinical features of patients with Behcet's disease (BD) in Mongolia., Methods: Patients were identified and examined from six medical institutions in Mongolia from January 2015 to January 2019. BD was diagnosed according to the diagnostic criteria for BD established by the International Study Group., Results: There were sixty-five patients (22 males and 43 females) recoded, the ratio of 1:1.95, with a marked female predominance. The age of disease onset was 22.2 ± 10.0 (mean ± SD), ranging from 11 to 66 years old. Oral aphthous ulcers, ocular lesions, skin lesions, genital ulcers, pathergy test positivity, articular lesions, superficial vasculitis, deep vein thrombosis, and epididymitis (male only) were observed in 100.0%, 63.1%, 81.5%, 89.2%, 7.7%, 86.2%, 32.3%, 4.6%, and 13.6% of the patients, respectively. The incidence of poor visual prognosis, ≤ 20/200, was significantly higher in males than in females (31.8 vs. 9.3%, incidence rate ratio 4.55 (95% CI 1.16-17.82), p < 0.05). The pathergy test was positive only in 7.7% of cases and only in female subjects. Nasal mucous ulcers were frequently seen in 55.4% of patients that may also be attributed to the environmental conditions of Mongolia. Headache was observed 76.9% of patients in this study., Conclusions: Clinical manifestations of BD in Mongolia are presented for the first time. The visual prognosis was significantly worse in males. Nasal mucous membrane ulcers and recurrent headaches were frequent among Mongolian patients with BD. Key Points • First results of the examination of the clinical features of Behcet's disease patients in Mongolia. • Nasal ulcerations and recurrent headaches are frequent symptoms in Mongolia Behcet's disease patients, potentially attributed to climate. • Male Behcet's disease patients in Mongolia have a significantly worse prognosis for eye-related complications and vision.
- Published
- 2020
- Full Text
- View/download PDF
44. Genetic control of CCL24, POR, and IL23R contributes to the pathogenesis of sarcoidosis.
- Author
-
Meguro A, Ishihara M, Petrek M, Yamamoto K, Takeuchi M, Mrazek F, Kolek V, Benicka A, Yamane T, Shibuya E, Yoshino A, Isomoto A, Ota M, Yatsu K, Shijubo N, Nagai S, Yamaguchi E, Yamaguchi T, Namba K, Kaburaki T, Takase H, Morimoto SI, Hori J, Kono K, Goto H, Suda T, Ikushima S, Ando Y, Takenaka S, Takeuchi M, Yuasa T, Sugisaki K, Ohguro N, Hiraoka M, Kitaichi N, Sugiyama Y, Horita N, Asukata Y, Kawagoe T, Kimura I, Ishido M, Inoko H, Mochizuki M, Ohno S, Bahram S, Remmers EF, Kastner DL, and Mizuki N
- Subjects
- Alleles, Chemokine CCL24 metabolism, Cytochrome P-450 Enzyme System metabolism, Female, Genetic Association Studies, Genome-Wide Association Study, Genotype, Humans, Japan, Male, Odds Ratio, Polymorphism, Single Nucleotide, Quantitative Trait Loci, Receptors, Interleukin metabolism, Sarcoidosis diagnosis, Sarcoidosis metabolism, Chemokine CCL24 genetics, Cytochrome P-450 Enzyme System genetics, Genetic Predisposition to Disease, Receptors, Interleukin genetics, Sarcoidosis etiology
- Abstract
Sarcoidosis is a genetically complex systemic inflammatory disease that affects multiple organs. We present a GWAS of a Japanese cohort (700 sarcoidosis cases and 886 controls) with replication in independent samples from Japan (931 cases and 1,042 controls) and the Czech Republic (265 cases and 264 controls). We identified three loci outside the HLA complex, CCL24, STYXL1-SRRM3, and C1orf141-IL23R, which showed genome-wide significant associations (P < 5.0 × 10
-8 ) with sarcoidosis; CCL24 and STYXL1-SRRM3 were novel. The disease-risk alleles in CCL24 and IL23R were associated with reduced CCL24 and IL23R expression, respectively. The disease-risk allele in STYXL1-SRRM3 was associated with elevated POR expression. These results suggest that genetic control of CCL24, POR, and IL23R expression contribute to the pathogenesis of sarcoidosis. We speculate that the CCL24 risk allele might be involved in a polarized Th1 response in sarcoidosis, and that POR and IL23R risk alleles may lead to diminished host defense against sarcoidosis pathogens.- Published
- 2020
- Full Text
- View/download PDF
45. The influence of HLA-B51 on clinical manifestations among Japanese patients with Behçet's disease: A nationwide survey.
- Author
-
Mizuki Y, Horita N, Horie Y, Takeuchi M, Ishido T, Mizuki R, Kawagoe T, Shibuya E, Yuda K, Ishido M, Minegishi K, Yoshimi R, Kirino Y, Kato S, Arimoto J, Fukumoto T, Kurosawa M, Kitaichi N, Takeno M, Kaneko T, and Mizuki N
- Subjects
- Adult, Behcet Syndrome blood, Female, Humans, Male, Middle Aged, Prevalence, Arthritis epidemiology, Behcet Syndrome complications, Gastrointestinal Diseases epidemiology, HLA-B51 Antigen blood, Ulcer epidemiology
- Abstract
Objectives: To scrutinize the influence of HLA-B51 to each clinical manifestation of patients with Behçet's disease (BD) using a database of the Ministry of Health, Labour and Welfare of Japan. Methods: The database of newly registered patients with BD was obtained from the Japanese Ministry of Health, Labour and Welfare. Patients who met International Criteria for Behçet's Disease (ICBD) and had data for HLA-B51 were selected and analyzed. Results: Among the 3044 analyzable cases, 1334 (43.8%) were men and 1710 (56.2%) were women; the median age was 38 years (IQR 29-48). HLA-B51 was positive for 1334 (44.5%). Prevalence of selected manifestations was 98.5% for oral ulceration, 85.5% for skin lesion, 42.1% for ocular lesion, 69.1% for genital ulceration, and 29.0% for gastrointestinal symptom. HLA-B51-positive patients had higher risk for ocular lesion (OR 1.59, 95%CI: 1.37-1.84; p < .001) and lower risk for genital ulceration (OR 0.72, 95%CI: 0.62-0.84; p < .001) and gastrointestinal symptom (OR 0.65, 95%CI: 0.55-0.77; p < .001). No significant difference was observed for other organ involvement; oral ulceration, skin lesion, positive pathergy test, arthritis, epididymitis, vascular lesion, or neurological manifestation. Subgroup analyses revealed that HLA-B51 was not related to genital ulceration in the cases with an ICBD score of 6 or higher and that HLA-B51 tended to more largely affect the risk of three manifestations for men compared to that for women. Conclusion: HLA-B51 positive is a risk factor for ocular lesion and vice versa for genital ulceration and gastrointestinal symptoms in patients with Japanese BD.
- Published
- 2020
- Full Text
- View/download PDF
46. Variants in IL23R-C1orf141 and ADO-ZNF365-EGR2 are associated with susceptibility to Vogt-Koyanagi-Harada disease in Japanese population.
- Author
-
Sakono T, Meguro A, Takeuchi M, Yamane T, Teshigawara T, Kitaichi N, Horie Y, Namba K, Ohno S, Nakao K, Sakamoto T, Sakai T, Nakano T, Keino H, Okada AA, Takeda A, Ito T, Mashimo H, Ohguro N, Oono S, Enaida H, Okinami S, Horita N, Ota M, and Mizuki N
- Subjects
- Adult, Alleles, Asian People genetics, Carotenoids, Case-Control Studies, Female, Gene Frequency, Genome-Wide Association Study, HLA-DR4 Antigen genetics, Humans, Japan, Male, Middle Aged, DNA-Binding Proteins genetics, Early Growth Response Protein 2 genetics, Genetic Predisposition to Disease, Oxygenases genetics, Polymorphism, Single Nucleotide, Receptors, Interleukin genetics, Transcription Factors genetics, Uveomeningoencephalitic Syndrome genetics
- Abstract
Vogt-Koyanagi-Harada (VKH) disease is a systemic inflammatory disorder that affects pigment cell-containing organs such as the eye (e.g., chronic and/or recurrent granulomatous panuveitis). While the exact etiology and pathogenic mechanism of VKH disease are unclear, HLA-DR4 alleles have been documented to be strongly associated with VKH disease in various ethnic groups. Recently, a genome-wide association study (GWAS) found two new genetic risk factors (IL23R-C1orf141 and ADO-ZNF365-EGR2) in a non-HLA region from a Han Chinese population. In this study, we replicated these GWAS findings in a Japanese population. A total of 1,643 Japanese samples (380 cases with VKH disease and 1,263 healthy controls) were recruited. We assessed four single nucleotide polymorphisms (SNPs) shown in previous GWAS: rs78377598 and rs117633859 in IL23R-C1orf141, and rs442309 and rs224058 in ADO-ZNF365-EGR2. A significant allelic association with VKH disease was observed for all of the four SNPs (rs78377598: pc = 0.0057; rs117633859: pc = 0.0017; rs442309: pc = 0.021; rs224058: pc = 0.035). In genotypic association analysis, the minor alleles of IL23R-C1orf141 rs78377598 and rs117633859 had the strongest association with disease susceptibility under the additive model (pc = 0.0075 and pc = 0.0026, respectively). The minor alleles of ADO-ZNF365-EGR2 rs442309 and rs224058 were most strongly associated with disease susceptibility under the dominant model (pc = 0.00099 and pc = 0.0023, respectively). The meta-analysis of the current and previous studies found that all of the four SNPs exhibited a significantly strong association with VKH disease (meta-p < 0.00001: rs78377598, meta-odds ratio (OR) = 1.69; rs1176338, meta-OR = 1.82; rs442309, meta-OR = 1.34; rs224058, meta-OR = 1.33). In summary, our study replicated significant associations with VKH disease susceptibility reported in a previous GWAS. Thus, the IL23R-C1orf141 and ADO-ZNF365-EGR2 loci may play important roles in the development of VKH disease through genetic polymorphisms., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2020
- Full Text
- View/download PDF
47. Attenuation of experimental autoimmune uveoretinitis in mice by IKKβ inhibitor IMD-0354.
- Author
-
Liu Y, Kitaichi N, Wu D, Hase K, Satoh M, Iwata D, Namba K, Kanda A, Noda K, Itai A, Iwabuchi K, and Ishida S
- Subjects
- Animals, Autoimmune Diseases immunology, Autoimmune Diseases pathology, Benzamides administration & dosage, Benzamides pharmacology, Cell Nucleus drug effects, Cell Nucleus metabolism, Cytokines biosynthesis, Edema complications, Edema pathology, I-kappa B Kinase metabolism, Inflammation complications, Inflammation pathology, Male, Mice, NF-kappa B metabolism, Retinitis immunology, Retinitis pathology, Severity of Illness Index, Th1 Cells drug effects, Th1 Cells immunology, Th17 Cells drug effects, Th17 Cells immunology, Uveitis immunology, Uveitis pathology, Autoimmune Diseases drug therapy, Benzamides therapeutic use, I-kappa B Kinase antagonists & inhibitors, Retinitis drug therapy, Uveitis drug therapy
- Abstract
Uveitis is a sight-threatening intraocular inflammatory disease that accounts for almost 10% of blindness worldwide. NF-κB signaling plays pivotal roles in inflammatory diseases. We have reported that IMD-0354, which inhibits NF-κB signaling via selective blockade of IKK-β, suppresses inflammation in several ocular disease models. Here, we examined the therapeutic effect of IMD-0354 in an experimental autoimmune uveoretinitis (EAU) model, a well-established animal model for endogenous uveitis in humans. Systemic administration of IMD-0354 significantly suppressed the clinical and histological severity, inflammatory edema, and the translocation of NF-κB p65 into the nucleus of retinas in EAU mice. Furthermore, IMD-0354 treatment significantly inhibited the levels of several Th1/Th17-mediated pro-inflammatory cytokines in vitro. Our current data demonstrate that inhibition of IKKβ with IMD-0354 ameliorates inflammatory responses in the mouse EAU model, suggesting that IMD-0354 may be a promising therapeutic agent for human endogenous uveitis., Competing Interests: Declaration of competing interest The authors declare no conflict of interest., (Copyright © 2020. Published by Elsevier Inc.)
- Published
- 2020
- Full Text
- View/download PDF
48. A 12-Week-Long Intake of Bilberry Extract ( Vaccinium myrtillus L.) Improved Objective Findings of Ciliary Muscle Contraction of the Eye: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Comparison Trial.
- Author
-
Kosehira M, Machida N, and Kitaichi N
- Subjects
- Accommodation, Ocular physiology, Administration, Oral, Adult, Double-Blind Method, Drug Administration Schedule, Female, Healthy Volunteers, Humans, Male, Middle Aged, Muscle, Smooth physiology, Plant Extracts, Treatment Outcome, Vaccinium myrtillus, Young Adult, Accommodation, Ocular drug effects, Anthocyanins administration & dosage, Eye drug effects, Muscle Contraction drug effects, Muscle, Smooth drug effects
- Abstract
A 12-week-long randomized, double-blind, placebo-controlled, parallel-group comparison trial was conducted to determine the effects of long-term standardized bilberry extract (SBE) intake on tonic accommodation of ciliary muscle caused by visual display terminal (VDT) tasks. This study was compliant with the accordance with CONSORT 2010 statement. A total of 109 healthy adult men and women aged 20-60 years were recruited and randomized into SBE and placebo groups. The subjects in the SBE and placebo groups were administered 240 mg of SBE and placebo, respectively, once daily for 12 weeks. Tests were performed before and after VDT tasks at week 0, 4, 8, and 12; high-frequency component (HFC)-1 value was the evaluation outcome. Results showed that post-load HFC-1 values at weeks 8 and 12 were significantly improved in the SBE group than in the placebo group ( p = 0.014 and 0.017, respectively). Regarding the difference between before and after the task load (ΔHFC-1), the values were significantly better in the SBE group than in the placebo group at week 4 and 12 ( p = 0.018 and 0.049, respectively). This study shows that oral consumption of 240 mg SBE extract for 12 weeks relieves the tonic accommodation of the ciliary muscle caused by VDT tasks and near-vision tasks., Competing Interests: M.K. and N.M. are employees of Omnica Co., Ltd., Japan.
- Published
- 2020
- Full Text
- View/download PDF
49. Curcumin inhibits the expression of proinflammatory mediators and MMP-9 in gingival epithelial cells stimulated for a prolonged period with lipopolysaccharides derived from Porphyromonas gingivalis.
- Author
-
Toraya S, Uehara O, Hiraki D, Harada F, Neopane P, Morikawa T, Takai R, Yoshida K, Matsuoka H, Kitaichi N, Chiba I, and Abiko Y
- Subjects
- Epithelial Cells, Gingiva, Humans, Lipopolysaccharides, Matrix Metalloproteinase 9, Curcumin, Porphyromonas gingivalis
- Abstract
Curcumin, a yellow phytochemical found in the rhizomes of Curcuma longa, has various biological effects, including anti-oxidant and anti-inflammatory activities. In the present study, we examined the effect of curcumin on the expression of inflammatory cytokines in human gingival epithelial progenitor cells (HGEPs) stimulated for a prolonged period with lipopolysaccharide (LPS) derived from Porphyromonas gingivalis. The cells were alternately cultured with LPS and/or curcumin every 3 days for 18 days. The expression levels of TNF-α, IL-1β, IL-6, TIMP-1, and MMP-9 in the HGEPs were evaluated by quantitative real-time polymerase chain reaction. Enzyme-linked immunosorbent assay was used to measure the concentrations of these five proteins in the supernatant and nuclear factor (NF)-κB in the nuclear extracts. Curcumin inhibited the mRNA expression levels of TNF-α, IL-1β, IL-6, and MMP-9 in HGEPs treated with curcumin over a prolonged period. Similarly, the expression levels of IL-1β, IL-6, and MMP-9 were decreased in the culture supernatants. NF-κB activity was also inhibited in the cells cultured with curcumin. In conclusion, these findings indicate that curcumin inhibits the expression of inflammatory cytokines and MMP-9 in primary gingival epithelial cells stimulated with P. gingivalis-derived LPS via NF-κB activation.
- Published
- 2020
- Full Text
- View/download PDF
50. Immunohistochemical and Immunocytochemical Analyses in Patients with Vitreoretinal Lymphoma.
- Author
-
Kase S, Namba K, Kanno-Okada H, Onozawa M, Hidaka D, Iwata D, Mizuuchi K, Fukuhara T, Fukuhara J, Kitaichi N, Matsuno Y, and Ishida S
- Subjects
- Aged, Aged, 80 and over, DNA Mutational Analysis, DNA, Neoplasm analysis, Eye Enucleation, Humans, Intraocular Lymphoma genetics, Intraocular Lymphoma surgery, Male, Mutation, Myeloid Differentiation Factor 88 genetics, Myeloid Differentiation Factor 88 metabolism, Retinal Neoplasms genetics, Retinal Neoplasms surgery, Retrospective Studies, Immunohistochemistry methods, Intraocular Lymphoma diagnosis, Retinal Neoplasms diagnosis, Vitreous Body diagnostic imaging
- Abstract
Purpose : The aim of this study was to analyze immunohistochemical and immunocytological findings by examining enucleated eyes and vitreous cell block (CB) in patients with vitreoretinal lymphoma (VRL). Methods : Histological specimens were obtained from two enucleated eyes with VRL associated with neovascular glaucoma. CB specimens were prepared in 18 patients from diluted waste fluids containing shredded vitreous. Histological and cytological specimens were submitted for hematoxylin-eosin staining and immunopathological analyses. Results : Both specimens demonstrated massive infiltration of large lymphoma cells. The lymphoma cells were positive for CD20 and MUM-1 in enucleated eyes. Membranous immunoreactivity for CD20 was observed in lymphoma cells in CB with VRL. Bcl-6 and MUM-1 were marked in five and eight out of nine cases examined, respectively Conclusions : Cytological findings in CB specimens indicated similar histopathological characteristics of enucleated eyes. CB specimens obtained from vitreous waste diluted fluids may serve as effective materials for cytological diagnosis of VRL.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.